Blood Clot Alert In Johnson and Johnson Shots

"After conducting an updated analysis, evaluation and investigation of reported cases, the FDA has determined that the risk of thrombosis with thrombocytopenia syndrome (TTS), a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets with onset of symptoms approximately one to two weeks following administration of the Janssen COVID-19 Vaccine, warrants limiting the authorized use of the vaccine. "

Articles
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-janssen-covid-19-vaccine-certain-individuals

https://www.statnews.com/2022/05/05/fda-limits-use-of-johnson-johnsons-covid-19-vaccine/

https://www.google.com/amp/s/amp.cnn.com/cnn/2022/05/05/health/fda-johnson-johnson-vaccine-eua/index.html

IG: kpontos
YouTube: Eat healthy live free